 CLEVELAND, Aug. 24, 2021 PRNewswire -- ViewRay, Inc. NASDAQ: VRAY today announced that the clinical team at Amsterdam University Medical Centers Amsterdam UMC has started offering same-day ablative treatment using MRIdian SMART stereotactic MR-guided adaptive radiotherapy for patients who are eligible for single fraction MRI-guided radiation therapy. Three patients under treatment for lung tumors were the first to benefit from this program. 